3-iodobenzylguanidine has been researched along with Cancer of Gastrointestinal Tract in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhanthumkomol, P; Hara, K; Hijioka, S; Hirayama, Y; Inaba, Y; Ishihara, M; Ito, A; Ito, Y; Kuwahara, T; Mizuno, N; Niwa, Y; Okuno, N; Onishi, S; Sasaki, E; Shimizu, Y; Tajika, M; Tanaka, T; Yatabe, Y | 1 |
| Bodoky, G; Pregun, I; Rácz, K; Tulassay, Z | 1 |
| Anthony, LB; Boudreaux, JP; Campeau, R; Cundiff, J; Go, VL; Joseph, S; O'Dorisio, T; Raines, D; Vinik, AI; Wang, YZ; Woltering, EA | 1 |
| Krenning, EP; Kwekkeboom, DJ; Teunissen, JJ; Valkema, R | 1 |
| Bal, CS; Naswa, N | 1 |
| Barthel, B; Beck, NI; Höpfner, M; Jockers-Scherübl, MC; Maaser, K; Scherübl, H; Sutter, AP; Zeitz, M | 1 |
| Ahlman, H; Bernhardt, P; Forssell-Aronsson, E; Jakobsen, AM; Kölby, L; Nilsson, O | 1 |
| Ahnert-Hilger, G; Höpfner, M; Huether, A; Scherübl, H; Sutter, AP | 1 |
| Aparicio, T; Askienazy, S; de Labriolle-Vaylet, C; Faraggi, M; Giraudet, AL; Mignon, M; Nguyen, C; Rouzet, F; Sobhani, I | 1 |
| McEwan, AJ; Pasieka, JL; Rorstad, O | 1 |
| Eriksson, B; Oberg, K | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Bucerius, J; Ezziddin, S; Fischer, HP; Logvinski, T; Palmedo, H; Reinhardt, MJ; Yong-Hing, C | 1 |
| Baum, RP; Calcagni, ML; Rufini, V | 1 |
| Chan, AK; Eick, G; Kidd, M; Latich, I; Modlin, IM; Zikusoka, M | 1 |
| Askienazy, S; de Labriolle-Vaylet, C; Lebtahi, R; Mure, A | 1 |
| Bukowski, RM; Pelley, RJ | 1 |
9 review(s) available for 3-iodobenzylguanidine and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
[Carcinoid tumors].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biomarkers, Tumor; Bronchial Neoplasms; Carcinoid Tumor; Chromogranin A; Clinical Trials as Topic; Dacarbazine; Early Detection of Cancer; Gastrointestinal Neoplasms; Heterocyclic Compounds; Humans; Hydroxyindoleacetic Acid; Lung Neoplasms; Organometallic Compounds; Prevalence; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Somatostatin; Temozolomide; Thalidomide; TOR Serine-Threonine Kinases; Treatment Outcome | 2010 |
Neuroendocrine tumors: current recommendations for diagnosis and surgical management.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemoembolization, Therapeutic; Combined Modality Therapy; Gastrointestinal Neoplasms; Humans; Iodine Radioisotopes; Neuroendocrine Tumors; Pancreatic Neoplasms; Practice Guidelines as Topic; Radionuclide Imaging; Somatostatin | 2011 |
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Gastrointestinal Neoplasms; Humans; Ligands; Magnetic Resonance Imaging; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Radioisotopes; Radionuclide Imaging; Receptors, Somatostatin; Tomography, X-Ray Computed | 2011 |
Divergent role of (68)Ga-labeled somatostatin analogs in the workup of patients with NETs: AIIMS experience.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin | 2013 |
Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Nuclear Medicine; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin | 2005 |
Imaging of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Adult; Carcinoma, Medullary; Catecholamines; Child; Gastrointestinal Neoplasms; Humans; Iodine Radioisotopes; Middle Aged; Neuroblastoma; Neuroendocrine Tumors; Octreotide; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Thyroid Neoplasms | 2006 |
Gastrointestinal carcinoids: the evolution of diagnostic strategies.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Capsule Endoscopy; Carcinoid Tumor; Chromogranin A; Endosonography; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin | 2006 |
[Imaging of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
Topics: 3-Iodobenzylguanidine; Amino Acid Sequence; Gastrointestinal Neoplasms; Humans; Intraoperative Care; Molecular Sequence Data; Neuroendocrine Tumors; Pancreatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin | 1998 |
Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Gastrointestinal Neoplasms; Humans; Iodine Radioisotopes; Neuroendocrine Tumors; Somatostatin | 1999 |
1 trial(s) available for 3-iodobenzylguanidine and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Long-term efficacy of radionuclide therapy in patients with disseminated neuroendocrine tumors uncontrolled by conventional therapy.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Salvage Therapy; Somatostatin; Survival Analysis; Terminal Care; Treatment Failure; Treatment Outcome | 2004 |
6 other study(ies) available for 3-iodobenzylguanidine and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Uptake of
Topics: 3-Iodobenzylguanidine; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Middle Aged; Multimodal Imaging; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Meta-iodobenzylguanidine induces growth inhibition and apoptosis of neuroendocrine gastrointestinal tumor cells.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Cycle; Cell Division; Colorectal Neoplasms; DNA Primers; Dose-Response Relationship, Drug; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Intracellular Membranes; L-Lactate Dehydrogenase; Membrane Potentials; Mitochondria; Neoplasm Proteins; Neuroendocrine Tumors; Norepinephrine Plasma Membrane Transport Proteins; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Symporters; Tumor Cells, Cultured | 2002 |
Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adenocarcinoma; Adrenal Gland Neoplasms; Adrenergic Uptake Inhibitors; Biopsy; Carcinoid Tumor; Chromogranins; Clomipramine; Gastrointestinal Neoplasms; GTP-Binding Protein alpha Subunits, Gs; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroblastoma; Neuroendocrine Tumors; Neuropeptides; Pancreatic Neoplasms; Pheochromocytoma; Radionuclide Imaging; Reserpine; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Tumor Cells, Cultured; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2004 |
A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-gamma and meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Caspases; Cell Cycle; Drug Synergism; G1 Phase; Gastrointestinal Neoplasms; Humans; Interferon-gamma; Neuroendocrine Tumors; Norepinephrine Plasma Membrane Transport Proteins; Receptors, Interferon; Resting Phase, Cell Cycle; Reverse Transcriptase Polymerase Chain Reaction; S Phase; Statistics, Nonparametric; Symporters; Tumor Cells, Cultured; Up-Regulation | 2004 |
The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cohort Studies; Female; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Palliative Care; Radiopharmaceuticals; Thyroid Neoplasms; Treatment Outcome | 2004 |
Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Digestive System Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Somatostatin | 2006 |